| pubmed-article:16061829 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16061829 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16061829 | lifeskim:mentions | umls-concept:C0001206 | lld:lifeskim |
| pubmed-article:16061829 | lifeskim:mentions | umls-concept:C0028833 | lld:lifeskim |
| pubmed-article:16061829 | lifeskim:mentions | umls-concept:C0520863 | lld:lifeskim |
| pubmed-article:16061829 | lifeskim:mentions | umls-concept:C0205322 | lld:lifeskim |
| pubmed-article:16061829 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:16061829 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:16061829 | pubmed:dateCreated | 2005-8-2 | lld:pubmed |
| pubmed-article:16061829 | pubmed:abstractText | This study was designed to evaluate potential reversibility of left-ventricular (LV) dysfunction in patients with acromegaly following long-term control of disease. It is unknown whether the cardiac changes induced by acromegaly can be reversed completely by long-term strict control of growth hormone excess by octreotide. | lld:pubmed |
| pubmed-article:16061829 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16061829 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16061829 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16061829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16061829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16061829 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16061829 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16061829 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:16061829 | pubmed:issn | 0804-4643 | lld:pubmed |
| pubmed-article:16061829 | pubmed:author | pubmed-author:RoelfsemaFF | lld:pubmed |
| pubmed-article:16061829 | pubmed:author | pubmed-author:PereiraA MAM | lld:pubmed |
| pubmed-article:16061829 | pubmed:author | pubmed-author:van der... | lld:pubmed |
| pubmed-article:16061829 | pubmed:author | pubmed-author:LinP LPL | lld:pubmed |
| pubmed-article:16061829 | pubmed:author | pubmed-author:RomijnJ AJA | lld:pubmed |
| pubmed-article:16061829 | pubmed:author | pubmed-author:PoldermansDD | lld:pubmed |
| pubmed-article:16061829 | pubmed:author | pubmed-author:HolmanE RER | lld:pubmed |
| pubmed-article:16061829 | pubmed:author | pubmed-author:LambH JHJ | lld:pubmed |
| pubmed-article:16061829 | pubmed:author | pubmed-author:BiermaszN RNR | lld:pubmed |
| pubmed-article:16061829 | pubmed:author | pubmed-author:SmitJ W AJW | lld:pubmed |
| pubmed-article:16061829 | pubmed:author | pubmed-author:van ThielS... | lld:pubmed |
| pubmed-article:16061829 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16061829 | pubmed:volume | 153 | lld:pubmed |
| pubmed-article:16061829 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16061829 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16061829 | pubmed:pagination | 231-8 | lld:pubmed |
| pubmed-article:16061829 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:meshHeading | pubmed-meshheading:16061829... | lld:pubmed |
| pubmed-article:16061829 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16061829 | pubmed:articleTitle | Persistent diastolic dysfunction despite successful long-term octreotide treatment in acromegaly. | lld:pubmed |
| pubmed-article:16061829 | pubmed:affiliation | Department of Endocrinology and Metabolism, Leiden University Medical Center, The Netherlands. | lld:pubmed |
| pubmed-article:16061829 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16061829 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:16061829 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16061829 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16061829 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16061829 | lld:pubmed |
